RE:RE:RE:RE:RE:RE:RE:Any analyst downgradesCould be. I have to admit my ears are a bit numb when it comes to THTX talking about bolt on acquisitions of product as they have talked about it for a very long time without delivering anything. Also, it seems improbable they wpould be able to pull off a deal that would actually generate good returns. But maybe they have finally come up with something. One reason for my skepticism surrounding this has been THTX's inability to finance any acquisition. They would need to structure something like Trogarzo and that seems like it was a one-off deal that is not easily repeated. But when asked about financing such an acquisition of a new product in the Q&A session Dubuc referred to entities that specialize in financing for such deals. So, maybe you are right and this is what we may soon hear about.
LouisW wrote: I agree TH needs a very good news desperately. But I am not quite sure that the news is related to oncology.
What impressed me was that Paul said "we are very active on the business development front, we have a very real opportunity to further accelerate our growth through bolt-on accretive acquisitions of existing brands, which can be quickly added into our commercial platform."
I guess we will probably hear the newsregarding the acquisition of new product soon.